# EDGAR Filing Document

**Accession Number:** 0001326205
**File Stem:** 0001185185-25-000843
**Filing Date:** 2025-7
**Character Count:** 2494
**Document Hash:** 0aa47144479b53b96f17ba0581d77085
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001185185-25-000843.hdr.sgml**: 20250825

**ACCESSION NUMBER**: 0001185185-25-000843

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 3

**FILED AS OF DATE**: 20250724

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** IGC Pharma, Inc.
- **CENTRAL INDEX KEY:** 0001326205
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 202760393
- **STATE OF INCORPORATION:** MD
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 10224 FALLS ROAD
- **CITY:** POTOMAC
- **STATE:** MD
- **ZIP:** 20854
- **BUSINESS PHONE:** 301-983-0998

**MAIL ADDRESS:**
- **STREET 1:** 10224 FALLS ROAD
- **CITY:** POTOMAC
- **STATE:** MD
- **ZIP:** 20854

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** India Globalization Capital, Inc.
- **DATE OF NAME CHANGE:** 20050505

![](image_001.jpg)

July 24, 2025

**<u>VIA EDGAR</u>**

U.S. Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attention: Chris Edwards, Esq. <br> Division of Corporation Finance

Re: IGC Pharma, Inc. <u>Registration Statement on Form S-3 (No. 333-288785)</u>

Ladies and Gentlemen:

On behalf of IGC Pharma, Inc. (the "Company"), we enclose the Company's request for acceleration of the above-referenced Registration Statement to 4:00 p.m., Eastern time, on Monday, July 28, 2025, or as soon as possible thereafter.

Please advise the undersigned of the effectiveness of the Registration Statement.

---

| |
|:---|
| Very truly yours, |
| /s/ *Kenneth Schlesinger* |
| Kenneth Schlesinger |

---

cc: Mr. Ram Mukunda Ms. Claudia Grimaldi

**IGC Pharma, Inc.** 

10224 Falls Road

Potomac, MD 20854

July 24, 2025

U.S. Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attention: Tim Buchmiller, Esq. <br> Division of Corporation Finance

Re: IGC Pharma, Inc. <u>Registration Statement on Form S-3 (No. 333-288785)</u>

Ladies and Gentlemen:

IGC Pharma, Inc. hereby requests that the effectiveness of the above-referenced Registration Statement be accelerated so that it will become effective at 4:00 p.m., Eastern time, on Monday, July 28, 2025, or as soon as possible thereafter.

---

| | |
|:---|:---|
| Very truly yours, | Very truly yours, |
| IGC PHARMA, INC. | IGC PHARMA, INC. |
| By: | /s/ *Ram Mukunda* |
|  | Ram Mukunda |
|  | Chief Executive Officer and President |

---